Abiopharma

West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie

Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy

NUTEX HEALTH RE-OPENS BAYOU CITY ER & HOSPITAL IN HOUSTON

New Resource for Cancer Patients: The LM Poster

Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results

Manufacturing process update for BAXTER HLTHCARE CORP. Submission: SUPPL-11. Decision date: 01/08/2026

Pink Limited symbol attribute type Security_Name was changed. Previous value: KIORA PHARM WT 7/27. New value: KIORA PHARM WTS 9/27/27.

General Announcement: Reconstitution of Board and Board Committees

General Announcement: Press Release - Appointment of New Chairman of the Board

Change - Announcement of Appointment: Change - Announcement of Appointment

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Change - Announcement of Cessation: Change - Announcement of Cessation

Athira Pharma Inc (ATHA) was removed from the list of traded instruments on NASDAQ exchange

General Announcement: MINUTES OF THE 2ND EXTRAORDINARY GENERAL MEETING OF THE COMPANY FOR FY2025 HELD ON 15 DECEMBER 2025

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Athira Pharma, Inc. - Common Stock.